Tag: mergers and acquisitions

September 18, 2018

Cancer Genetics Merges with NovellusDx

Two companies with similar oncology goals, Cancer Genetics and NovellusDx, have signed a definitive merger agreement, announced Tuesday.
September 18, 2018

Cancer Genetics and NovellusDx Sign Definitive Agreement to Merge

Cancer Genetics (Nasdaq:CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, and...
September 11, 2018

Invuity to be Acquired by Stryker, Share Price Increases

Invuity announced on Tuesday that it will be acquired by Stryker for US$7.40 per share, which comes to US$190 million.
September 6, 2018

Shire Acquires sanaplasma AG Boosting Plasma Collection Network for Immunology Franchise

Shire (LSE:SHP, NASDAQ:SHPG) announces the acquisition of sanaplasma AG, a source plasma collection company headquartered in Switzerland. The acquisition of...
August 26, 2018

5 Top Weekly NASDAQ Biotech Stocks: Bellerophon Leads the Pack

Bellerophon Therapeutics, Chiasma, BioLife Solutions, Cerecor and MiMedx Group were last week's top gainers on the NASDAQ Biotechnology Index.
August 12, 2018

5 Top Weekly NASDAQ Biotech Stocks: Vericel Takes Top Spot

Vericel, AcelRx, Tetraphase Pharmaceuticals, KalVista and Infinity Pharmaceuticals were last week's top gainers on the NASDAQ Biotechnology Index.
July 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: resTORbio Leads the Pack

resTORbio, ADMA Biologics, Misonix, Novus Therapeutics and Innovate Biopharmaceuticals were last week's top gainers on the NASDAQ Biotechnology Index.
July 16, 2018

What Is In-Licensing?

Licensing deals might be pharma’s preferred mode of business development these days—perhaps even more so than outright acquisitions. Read on...
July 15, 2018

5 Top Weekly NASDAQ Biotech Stocks: Arbutus on Top

Adamis Pharmaceutical, Juniper Pharmaceuticals, Anavex Life Sciences, Arbutus BioPharma and Soleno Therapeutics were last week's top gainers on the NASDAQ...
June 12, 2018

Medidata Defines the Future of Life Sciences with Acquisition of SHYFT Analytics

Medidata (NASDAQ:MDSO) today announced that it has entered into a definitive agreement to acquire SHYFT Analytics, bringing the leading platform for clinical...